CAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Count Me In, a non-profit research initiative, has launched the Brain Cancer Project (BrainCancerProject.org), a patient-partner

TORONTO, Sept. 4, 2019 /PRNewswire/ - Catalyst, the global nonprofit focused on accelerating progress for women at work, announced today that Susan Bartlett, Chief Executive Officer of the award-winning service design consultancy

BROKEN ARROW, Okla., Sept. 4, 2019 /PRNewswire/ -- A new study, released today by Broken Arrow Public Schools and CloroxPro, has shown the positive impact of daily disinfection in a school environment by using the Clorox® Total 360® System. After implementing the system daily throughout the 2018-19 schoo

CARLSBAD, Calif., Sept. 4, 2019 /PRNewswire/ -- Prescient Metabiomics, a privately held company and a subsidiary of Prescient Medicine Holdings, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted the company's submission for Breakthrough Device designation to its LifeKit® Prevent Colorectal Neoplasia Test. This Breakthro

RADNOR, Pa., Sept. 4, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield, President and Chief Executive Officer, and Tom

BETHESDA, Md., Sept. 4, 2019 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has expanded its senior management team with the addition of Dr. Kevin T. Duffy as Vice President, Medical Affairs and E

DALLAS, Sept. 4, 2019 /PRNewswire/ -- Richie Jaynes is proud to announce his newest venture. 

EWING, N.J., Sept. 4, 2019 /PRNewswire/ -- GS1 US® has published a new Implementation Guideline titled

ROCKVILLE, Md., Sept. 4, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that J.J. Finkelstein, President and Chief Executive Officer, will present a corporate update at The Fall Investor Sum

AUBURN, Calif., Sept. 4, 2019 /PRNewswire/ -- TCS Healthcare Technologies (TCS), a leading provider of population health and managed care software, is pleased to announce that Matt Fahner has been appointed Vice President of Engineering. In this new role, Mr. Fahner will oversee the development of all TCS products.